No Data
No Data
No Data
Core One Labs Extends Private Placement
Core One Labs Initiates $1.5 Million Private Placement
Core One Labs Signs Initial Agreement for Potential Sale of Proprietary Biosynthetic Psilocybin
Core One Labs Enters Into LOI For First Sale Of Its Psychedelic Compounds
GMP Drug Inc., a wholly-owned subsidiary of Core One Labs Inc. (OTCQB:CLABF) (CSE:COOL)(Frankfurt:LD6) (WKN: A3CSSU) has entered into a non-binding letter of intent with Zollaris Laboratories Corporat
Core One Labs Says in Talks With Multiple Companies to Supply Psilocybin; COOL Gained 15% on Friday
09:19 AM EDT, 05/08/2023 (MT Newswires) -- Core One Labs Inc. (COOL.CSE), which gained 15% on Friday, over the weekend said it is in discussions with several pharmaceutical laboratories and research o
Core One Labs (OTCMKTS:CLABD) Trading Up 1.9%
Core One Labs, Inc. (OTCMKTS:CLABD – Get Rating) rose 1.9% during trading on Tuesday . The stock traded as high as 0.34 and last traded at 0.34. Approximately 1,076 shares were traded during trading,
No Data